NEW ENTERPRISE ASSOCIATES
other names
- NEW ENTERPRISE ASSOCIATES
- NEA MANAGEMENT COMPANY, LLC
Adviser Profile
|
Exempt Reporting Adviser
2B(1)-VC
|
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 |
Private Funds
Employees
Top Holdings
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker03940C100 | Stock NameArcellx, Inc. | $ Position$349,656,983 | % Position20.00% | $ Change76.00% | # Change0.00% |
| Stck Ticker15102K100 | Stock NameCelcuity Inc. | $ Position$260,873,933 | % Position15.00% | $ Change-26.00% | # Change-35.00% |
| Stck Ticker85220G109 | Stock NameSpyglass Pharma, Inc. | $ Position$191,534,519 | % Position11.00% | $ Change | # Change |
| Stck Ticker89532M101 | Stock NameTrevi Therapeutics, Inc. | $ Position$157,741,180 | % Position9.00% | $ Change-5.00% | # Change0.00% |
| Stck Ticker805111101 | Stock NameSavara, Inc. | $ Position$133,613,101 | % Position8.00% | $ Change-9.00% | # Change0.00% |
| Stck Ticker61225M102 | Stock NameMonte Rosa Therapeutics, Inc. | $ Position$126,538,302 | % Position7.00% | $ Change5.00% | # Change0.00% |
| Stck Ticker55287L101 | Stock NameMBX Biosciences, Inc. | $ Position$107,892,407 | % Position6.00% | $ Change-5.00% | # Change0.00% |
| Stck Ticker98937L105 | Stock NameZenas BioPharma, Inc. | $ Position$78,653,931 | % Position4.00% | $ Change-39.00% | # Change14.00% |
| Stck Ticker22266M104 | Stock NameCoursera, Inc. | $ Position$74,890,416 | % Position4.00% | $ Change-21.00% | # Change0.00% |
| Stck TickerH17182108 | Stock NameCRISPR Therapeutics AG | $ Position$50,356,175 | % Position3.00% | $ Change-9.00% | # Change0.00% |